Boston Scientific EVP David Pierce to retire; Butcher and Jones to assume new roles

BOSTON SCIENTIFIC CORP

David A. Pierce, EVP and president MedSurg & Endoscopy, retiring effective July 4, 2022.
Arthur C. Butcher becomes EVP and group president MedSurg & Asia Pacific effective May 2, 2022.
Michael Jones becomes SVP and president Endoscopy effective May 2, 2022.
Pierce joined in 1991 and will lead transition of responsibilities until retirement.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

David A. Pierce

executive vice president and president, MedSurg and president, Endoscopy

BSX · BOSTON SCIENTIFIC CORP

Effective: 2022-07-04
Filed: April 5, 2022, 7:59 PM ET

On March 30, 2022, David A. Pierce, executive vice president and president, MedSurg and president, Endoscopy, informed Boston Scientific Corporation (“Boston Scientific” or the “Company”), that he will retire, effective July 4, 2022.

Role change

Arthur C. Butcher

executive vice president and group president, MedSurg and Asia Pacific

BSX · BOSTON SCIENTIFIC CORP

Effective: 2022-05-02
Filed: April 5, 2022, 7:59 PM ET

Arthur C. Butcher, currently executive vice president and president, Asia Pacific, will change roles and serve as executive vice president and group president, MedSurg and Asia Pacific

Role change

Michael Jones

senior vice president and president, Endoscopy

BSX · BOSTON SCIENTIFIC CORP

Effective: 2022-05-02
Filed: April 5, 2022, 7:59 PM ET

Michael Jones, currently senior vice president and general manager, Endoscopy, will change roles and serve as senior vice president and president, Endoscopy.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

David A. Pierce departed as executive vice president and president, MedSurg and president, Endoscopy at BOSTON SCIENTIFIC CORP.

Action: retire
Role: executive vice president and president, MedSurg and president, Endoscopy

Exact text from the filing

On March 30, 2022, David A. Pierce, executive vice president and president, MedSurg and president, Endoscopy, informed Boston Scientific Corporation (“Boston Scientific” or the “Company”), that he will retire, effective July 4, 2022.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Arthur C. Butcher changed role as executive vice president and group president, MedSurg and Asia Pacific at BOSTON SCIENTIFIC CORP.

Action: change roles
Role: executive vice president and group president, MedSurg and Asia Pacific

Exact text from the filing

Arthur C. Butcher, currently executive vice president and president, Asia Pacific, will change roles and serve as executive vice president and group president, MedSurg and Asia Pacific

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael Jones changed role as senior vice president and president, Endoscopy at BOSTON SCIENTIFIC CORP.

Action: change roles
Role: senior vice president and president, Endoscopy

Exact text from the filing

Michael Jones, currently senior vice president and general manager, Endoscopy, will change roles and serve as senior vice president and president, Endoscopy.

View on SEC.gov

BOSTON SCIENTIFIC CORP filing history →

Source: SEC EDGAR

accession 0000885725-22-000009

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.